Medications for Chronic Myelomonocytic Leukemia

3 results

  • Azacitidine (azacitidine)

    (AZACITIDINE)
    Eugia US LLC
    Usage: Azacitidine for injection is indicated for treating adult patients with specific myelodysplastic syndrome subtypes, including refractory anemia, refractory anemia with ringed sideroblasts (with complications), refractory anemia with excess blasts, and chronic myelomonocytic leukemia. Pediatric use is not labeled due to marketing exclusivity.

  • Azacitidine (azacitidine)

    (azacitidine)
    Wockhardt USA LLC.
    Usage: Azacitidine for injection is indicated for treating myelodysplastic syndromes (MDS), including refractory anemia (with or without ringsideroblasts), refractory anemia with excess blasts, and chronic myelomonocytic leukemia (CMMoL).

  • Azacitidine (azacitidine)

    (Azacitidine)
    Cipla USA Inc.
    Usage: Azacitidine for injection is indicated for adult patients with myelodysplastic syndromes (MDS), specifically subtypes such as refractory anemia, refractory anemia with ringed sideroblasts, refractory anemia with excess blasts, and chronic myelomonocytic leukemia.